Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/europace/euaf211 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of cryoballoon size adjustability on procedural and clinical outcomes.
Europace
September 2025
Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan.
SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes.
BMC Cardiovasc Disord
August 2025
Department of Cardiology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, China.
Background: The impact of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial tachyarrhythmia (ATa) recurrence in patients undergoing cryoballoon ablation is not well understood.
Methods: To evaluate the impact of SGLT2i on Ata recurrence in atrial fibrillation (AF) patients with and without diabetes, we conducted a prospective observational cohort study at a tertiary care hospital in China. A total of 582 adult patients who underwent cryoballoon ablation were included.
Assessing the value of routine preprocedural CT angiography in cryoballoon pulmonary vein isolation: a prospective, propensity score-matched study.
Int J Cardiol Heart Vasc
October 2025
Gottsegen National Cardiovascular Center, Budapest, Hungary.
Background: We aimed to evaluate the impact of routine preprocedural left atrial and coronary computed tomography angiography (CTA) on procedural strategies and clinical outcomes in patients undergoing cryoballoon pulmonary vein isolation (PVI).
Methods: In this prospective, propensity score-matched study, we analyzed patients who underwent cryoballoon PVI at our institution between January 2019 and March 2023. Patients were assigned to either a CTA group, where preprocedural CTA was performed, or a control group, where PVI was guided by fluoroscopy alone.
Changes in heart rate variability parameters following pulsed-field ablation in patients with atrial fibrillation: A systematic review and meta-analysis HRV changes after pulsed-field ablation in AF.
Int J Cardiol Heart Vasc
October 2025
Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Introduction: Atrial fibrillation (AF) is a prevalent cardiac arrhythmia. Pulmonary vein isolation (PVI) is a cornerstone for catheter ablation for AF. Most recently, pulsed-field ablation (PFA) has emerged as a novel technique that minimizes tissue damage due to its tissue selectivity with promising clinical success.
View Article and Find Full Text PDFThe Impact of Comorbidities on Pulmonary Function Measured by Spirometry in Patients After Percutaneous Cryoballoon Pulmonary Vein Isolation Due to Atrial Fibrillation.
J Clin Med
August 2025
Department of Electrocardiology, Medical University of Lodz, 92-213 Lodz, Poland.
Pulmonary vein isolation (PVI) via cryoballoon ablation (CBA) is a recommended therapeutic strategy for patients with symptomatic paroxysmal and persistent atrial fibrillation (AF) who are refractory to antiarrhythmic drugs. Although PVI has demonstrated efficacy in reducing AF recurrence and improving patients' quality of life, its impact on respiratory function is not well understood, particularly in patients with comorbid conditions. The aim of the study was to search for functional predictors of the respiratory system in the process of evaluating the efficiency of clinical assessment of CBA in patients with AF.
View Article and Find Full Text PDF